Cytokine release syndrome caused by immune checkpoint inhibitors: a case report and literature review
Immune checkpoint inhibitors (ICIs) have gained widespread application in the treatment of malignant tumors. Cytokine release syndrome (CRS) is a systemic inflammatory response triggered by various factors, including infections and immunotherapy. We present a case of CRS occurring in a gastric cance...
Saved in:
| Main Authors: | Xiuping Zhang, Yang You, Pengfei Zhang, Yan Wang, Feng Shen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Future Science OA |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20565623.2024.2422786 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytokine release syndrome after treatment with immune checkpoint inhibitors: an observational cohort study of 2672 patients from Karolinska University Hospital in Sweden
by: Osama Hamida, et al.
Published: (2024-12-01) -
Cytokine release syndrome in non- small cell lung cancer patient receiving immune checkpoint inhibitors: A case report
by: Ana Geltar, et al.
Published: (2025-03-01) -
Late-onset and relapsed cytokine release syndrome after nivolumab treatment in a patient with head and neck squamous cell carcinoma: a case report
by: Tomoyuki Otsuka, et al.
Published: (2025-02-01) -
Cytokine release syndrome treated with tocilizumab following ipilimumab–nivolumab combination therapy in advanced renal cell carcinoma
by: Toru Inoue, et al.
Published: (2025-01-01) -
Novel Composite Scoring System for Predicting Prognosis in Stage IV Gastric Cancer Patients Treated with Immune Checkpoint Inhibitors
by: Yang L, et al.
Published: (2025-05-01)